Block Drug Corporation has approval to use Atridox™ (10.0% doxycycline hyclate) in the ATRIGEL® delivery system for the treatment of periodontal disease. Atridox™ offers a new treatment option that is both effective and comfortable for the millions of Americans plagued with infected, inflamed gums associated with periodontal disease.
Atridox™ combines the antibiotic doxycycline with a unique gel that the dentist applies to periodontal pockets to fight the bacteria that cause this chronic infection in adults. Atridox™ continuously releases the antibiotic over seven days to safely fight the periodontal infection.
For more details, contact Block Drug Corporation at (800) 365-6500.
